3 October 2024
Citryll and leading rheumatology centres receive Reumanederland grant to collaborate on NET research to advance novel treatments for rheumatoid arthritis.
Citryll, a clinical-stage biotech company developing first-inclass therapeutics to treat immune-mediated inflammatory diseases, today announces a groundbreaking collaboration...